Clinical Trial Update: Propylene Glycol-Free Melphalan HCl (EVOMELA®) in Combination With Fludarabine and Total Body Irradiation Based Reduced Intensity Conditioning for Haploidentical Transplantation [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating propylene glycol-free melphalan HCl (EVOMELA) with fludarabine and total body irradiation-based reduced-intensity conditioning for ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• EVOMELA (melphalan hydrochloride)
• Fludarabine (Fludarabine)

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Hematological Malignancy, Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2026-01-27